Cln2 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cln2 monoclonal antibodies for research focused on understanding Cln2 protein functions. Cln2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cln2 plays essential roles in cellular processes, particularly in the regulation of cell cycle progression and apoptosis. Research has shown that Cln2 dysregulation is linked to various diseases, making it a significant focus in cancer and neurodegenerative disorder studies. Understanding Cln2 function and regulation can reveal potential therapeutic targets and disease mechanisms. Ongoing research continues to uncover new aspects of Cln2's role in cellular pathways and disease development. Advanced detection methods and specific protocols are available to optimize experimental results. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), allowing for versatile experimental design. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Cln2's role in health and disease.